Inovio stock rallies after company gets Gates Foundation grant to test device for coronavirus vaccine

Inovio Pharmaceuticals Inc. said Thursday it has received a $5 million grant from the Bill and Melinda Gates Foundation to accelerate the testing of a proprietary smart device for intradermal delivery of a vaccine to treat the coronavirus that causes COVID-19.